Skip to content
★ Sign in to follow
KA

KRM Ayurveda Limited Stock: price and insider trades · India

No insider purchase over the last 90 days. The latest, by SOM DEV DHAWAN, was filed 27 Mar 2026.

KRM Ayurveda Limited: what insiders have been doing

Every trade that managers of KRM Ayurveda Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 8 November 2026, 15 filings were filed, from 3 insiders.

Not one open-market sale was filed. On the buying side, 3 insiders reported 15 purchases totalling €734k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €87k from Puneet Dhawan, disclosed on 12 March 2026. Those buying include 2 major shareholders.

For context, the typical company on the same exchange (median of 1,985 companies) published 4 filings over the same period, against 15 filings here. The full history, which starts in 2026, counts 15 purchases against no sales.

In the case of 14 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The most recent open-market purchase was published on 27 March 2026, 226 days ago. Filings reach the SEBI (PIT + SAST) feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.

Insider Decl.
15
Thresholds
n/a
Buy Volume
€734,116
15 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
Som Dev Dhawan10 buys
Puneet Dhawan5 buys

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

· cache

Last declaration on 27 March 2026
Declarations15 total
  • ▲
    Immediate relativeExecutives
    7M INR18SEBI
    36,000 shares@ ₹194.677813.0% of flowEquity SharesSEBI:23797fb8753b0b3061762ca618bf765a4bc13fd3
    Canonical exit: 22 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    10M INR19SEBI
    48,000 shares@ ₹198.090617.5% of flowEquity SharesSEBI:a757c19c268fedbd02557aaf17c97bbcaf39bda1
    Canonical exit: 25 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    3M INR18SEBI
    16,000 shares@ ₹197.40635.8% of flowEquity SharesSEBI:47daf6a17b11a1186684cea790e51d123e54ea22
    Canonical exit: 23 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    4M INR18SEBI
    21,000 shares@ ₹194.007.7% of flowEquity SharesSEBI:f92f156642ba1c948f079251fa0113849015c37d
    Canonical exit: 11 Jun 2026 (T+90)
  • ▲
    PromotersExecutives
    2M INR21SEBI
    12,000 shares@ ₹203.4512.5% of flowEquity SharesSEBI:59f212cea096aefecf1137aa9d6dac365ef828af
    Canonical exit: 8 Jun 2026 (T+90)
  • ▲
    PromotersExecutives
    9M INR25SEBI
    47,000 shares@ ₹198.819147.8% of flowEquity SharesSEBI:e71bf97e7b9880aea02d02bef7f68991e11ab35d
    Canonical exit: 9 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    9M INR19SEBI
    45,000 shares@ ₹205.194417.3% of flowEquity SharesSEBI:4511a4a7c536dd5feb115157151fa2e00a101d0d
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    PromotersExecutives
    8M INR24SEBI
    38,000 shares@ ₹205.368439.8% of flowEquity SharesSEBI:5b305509e0386b449dc765c0c135edb0a387f1a5
    Canonical exit: 7 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    1M INR17SEBI
    7,000 shares@ ₹198.752.6% of flowEquity SharesSEBI:06b9ded7dc811e6aefce47221ce5a78bb0995360
    Canonical exit: 9 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    586,500 INR14SEBI
    3,000 shares@ ₹195.501.1% of flowEquity SharesSEBI:198e7604dac28f028112fdb6b2bb9ced0edfb9d8
    Canonical exit: 3 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    5M INR15SEBI
    26,000 shares@ ₹193.90589.4% of flowEquity SharesSEBI:3f3eaf741ccdae0505da94c9e3e82f1c0e90598e
    Canonical exit: 2 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    6M INR15SEBI
    18,000 shares@ ₹325.136111.0% of flowEquity SharesSEBI:633faf12a73838f84f7b9ce8df4bf7e085a613d6
    Canonical exit: 4 Jun 2026 (T+90)
  • ▲
    Immediate relativeExecutives
    8M INR15SEBI
    40,000 shares@ ₹198.767514.7% of flowEquity SharesSEBI:06e5556ed868ac63239935dfcba5318b4217d2a6
    Canonical exit: 31 May 2026 (T+90)
  • ▲
    PromotersExecutives
    4M INR24SEBI
    18,000 shares@ ₹206.886167.4% of flowEquity SharesSEBI:854f1190ba3d73726b6441f4b1c68d1d3defe08b
    Canonical exit: 4 Jun 2026 (T+90)
  • ▲
    PromotersExecutives
    2M INR8SEBI
    9,000 shares@ ₹202.055632.6% of flowEquity SharesSEBI:6429e1e3f981aedaa203518a9af6c4f736fc65c8
    Canonical exit: 28 May 2026 (T+90)

15 of 15 declarations

About KRM Ayurveda Limited

KRM Ayurveda Limited is a company focused on the health and pharmaceutical sector, providing products and services related to Ayurveda. It is listed on the XBOM market.